0920-0612 WISEWOMAN Program MDE Manual Version 9.0 July 2013

OMB No. 0920-0612
Exp. 12/31/2018

WISEWOMAN
Program
MDE Manual
Version 9.0
July 2013

Public reporting burden of this collection of information is estimated to average 24 hours per
response, including the time for reviewing instructions, searching existing data sources, gathering
and maintaining the data needed, and completing and reviewing the collection of information. An
agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding
this burden estimate or any other aspect of this collection of information, including suggestions
for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74,
Atlanta, Georgia 30333; ATTN: PRA (0920-0612).

CONTENTS
Item 0a: MDEver .............................................................................................................. 1
Item 1a: StFIPS ................................................................................................................ 2
Item 1b: HdANSI .............................................................................................................. 3
Item 1c: EnrollSiteID ....................................................................................................... 4
Item 1d: ScreenSiteID .................................................................................................... 5
Item 2a: TimePer ............................................................................................................. 6
Item 2b: NScreen ............................................................................................................. 7
Item 2c: Type ................................................................................................................... 8
Item 3a: EncodeID ........................................................................................................... 9
Item 3b: ResANSI ......................................................................................................... 10
Item 3c: ZIP ................................................................................................................ 11
Item 3d: MYB ................................................................................................................ 12
Item 3e: Latino ............................................................................................................... 13
Item 3f: Race1 ............................................................................................................... 14
Item 3g: Race2 .............................................................................................................. 15
Item 3h: Education ....................................................................................................... 16
Item 3i: Language ........................................................................................................ 17
Item 4a: SRHC .............................................................................................................. 18
Item 4b: SRHB .............................................................................................................. 19
Item 4c: SRD ................................................................................................................ 20
Item 4d: SRHA .............................................................................................................. 21
Item 5a: HCMeds .......................................................................................................... 22
Item 5b: HBPMeds ....................................................................................................... 23
Item 5c: DMeds ............................................................................................................. 24
Item 5d: HCAdhere....................................................................................................... 25
Item 5e: HBPAdhere .................................................................................................... 26
Item 5f: DAdhere .......................................................................................................... 27
Item 6a: BPHome ......................................................................................................... 28
Item 6b: BPFreq ............................................................................................................ 29
Item 6c: BPSend ........................................................................................................... 30
Item 7a: Fruit ................................................................................................................ 31
Item 7b: Vegetables ..................................................................................................... 32
Item 7c: Fish ................................................................................................................ 33
Item 7d: Grains .............................................................................................................. 34
Item 7e: Sugar ............................................................................................................... 35
Item 7f: SaltWatch ........................................................................................................ 36
Item 8a: PAMod ............................................................................................................ 37
Item 8b: PAVig .............................................................................................................. 38
Item 9a: Smoker ............................................................................................................ 39
Item 9b: Sechand.......................................................................................................... 40
Item 10a: QOLPH ......................................................................................................... 41
Item 10b: QOLMH ........................................................................................................ 42
Item 10c: QOLEffect .................................................................................................... 43
Item 11a: Height ............................................................................................................ 44
Item 11b: Weight ........................................................................................................... 45

Item 11c: Waist ............................................................................................................. 46
Item 11d: Hip ................................................................................................................ 47
Item 12a: BPDate ......................................................................................................... 48
Item 12b: SBP1 ............................................................................................................. 49
Item 12c: DBP1 ............................................................................................................. 50
Item 12d: SBP2 ............................................................................................................. 51
Item 12e: DBP2 ............................................................................................................. 52
Item 13a: Fast ................................................................................................................ 53
Item 14a: TCDate ......................................................................................................... 54
Item 14b: TotChol ......................................................................................................... 55
Item 14c: HDL ................................................................................................................ 56
Item 14d: LDL ................................................................................................................ 57
Item 14e: Trigly ............................................................................................................. 58
Item 15a: BGDate ......................................................................................................... 59
Item 15b: Glucose ........................................................................................................ 60
Item 15c: A1C ............................................................................................................... 61
Item 16a: BPAlert .......................................................................................................... 62
Item 16b: BPDiDate ..................................................................................................... 63
Item 16c: BGAlert ......................................................................................................... 64
Item 16d: BGDiDate ..................................................................................................... 65
Item 17a: RRCDate ...................................................................................................... 66
Item 17b: RRCComplete ............................................................................................. 67
Item 17c: RRCNut ........................................................................................................ 68
Item 17d: RRCPA ......................................................................................................... 69
Item 17e: RRCSmoke .................................................................................................. 70
Item 17f: RRCMedAdhere ......................................................................................... 71
Item 18a: RTCDate ...................................................................................................... 72
Item 18b: RTC ............................................................................................................... 73
Item 19a: RefDate ........................................................................................................ 74
Item 20a: LSPHCRec .................................................................................................. 75
Item 20b: Intervention .................................................................................................. 76
Item 20c: LSPHCID ...................................................................................................... 77
Item 20d: LSPHCTime................................................................................................. 78
Item 20e: ContactType ................................................................................................ 79
Item 20f: Setting ........................................................................................................... 80
Item 20g: LSPHCComp ............................................................................................... 81
Item 21a: TobResDate ................................................................................................ 82
Item 21b: TobResType ................................................................................................ 83
Item 21c: TobResComp .............................................................................................. 84

ii

Item 0a: MDEver

MDE Version
This variable indicates the version of the MDE that was used to collect and report data in the file.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All records in the Screening and Assessment file that are eligible for MDE submission

VALUES AND
DESCRIPTION

900 MDE version 9.00

ANALYSIS AND USE

To verify the MDE version used to collect and report data the file

MDE version 9.00 should be used to collect and report data
associated with screening visits conducted July 1, 2013, and after

1

Item 1a: StFIPS

State/Tribal FIPS Code
This variable indicates the FIPS or tribal program code for the state or tribe where the administration
of the program is located.

SOURCE

National FIPS Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

(State and Tribe values will be determined upon award of new funding)

ANALYSIS AND USE

To calculate the number of women screened by each state or tribal program
To assess the reach of the WISEWOMAN Program nationally and within a particular state or tribe

2

Item 1b: HdANSI

ANSI Geographic Code (Provider)
This indicates the ANSI geographic code of the provider that conducts the WISEWOMAN screening
office visit.

SOURCE

National ANSI Code List, Census Bureau

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

ANSI Geographic Code

ANALYSIS AND USE

To assess whether programs and specific providers are meeting screening goals in targeted
geographic areas
To identify geographic areas where women have access to the WISEWOMAN Program
To provide information for GIS analysis
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services

Value representing the geographic area of the provider that conducts
the screening office visit

3

Item 1c: EnrollSiteID

Enrollment Site ID
This variable indicates the site of a woman’s enrollment into the WISEWOMAN Program.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Enrollment Site ID

ANALYSIS AND USE

To identify sites where outreach and enrollment are occurring
To identify sites where the Program is being administered and participants are tracked
To track the number of WISEWOMAN participants enrolled at each WISEWOMAN enrollment site

ID code of the enrollment site, as developed and assigned by the
grantee

4

Item 1d: ScreenSiteID

Screening Site ID
This variable indicates the site where a woman received her WISEWOMAN screening.

SOURCE

National Provider Identifier

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Screening Site ID

ANALYSIS AND USE

To identify the geographic locations of sites providing screening services to participants
To track the number of WISEWOMAN participants screened at each WISEWOMAN screening site
To describe differences in participant demographics or other characteristics by screening site To
provide information for GIS analysis
To identify the number of screening providers in a given geographic area
To identify provider pool for assessment of health systems and providers that use clinical systems of
care successful in blood pressure control

Value representing a National Provider Identifier for the provider who
conducts the screening office visit

5

Item 2a: TimePer

Time Period of Screening
This variable indicates the 6-month time period of the baseline screening for the participant.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

01 6-month period 1

Baseline screening took place between 07/01/13 and 12/31/13

02 6-month period 2

Baseline screening took place between 01/01/14 and 06/30/14

03 6-month period 1

Baseline screening took place between 07/01/14 and 12/31/14

04 6-month period 2

Baseline screening took place between 01/01/15 and 06/30/15

05 6-month period 1

Baseline screening took place between 07/01/15 and 12/31/15

06 6-month period 2

Baseline screening took place between 01/01/16 and 06/30/16

07 6-month period 1

Baseline screening took place between 07/01/16 and 12/31/16

08 6-month period 2

Baseline screening took place between 01/01/17 and 06/30/17

ANALYSIS AND USE

To track participants over the course of the FOA by their baseline screenings
To track the number of unique participants programs have screened

6

Item 2b: NScreen

Number of Screenings Received by the Participant
This variable indicates the number of screenings/rescreenings the participant has received since the
beginning of the FOA.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of Visits

ANALYSIS AND USE

To track the number of screenings/rescreenings that the participant has received

Value representing the number of screenings/rescreenings the participant
has received since the beginning of the FOA (includes current screening)

7

VALUES AND
DESCRIPTION

Item 2c: Type

1 Screening

Record represents a baseline screening visit

2 Rescreening

Record represents a rescreening visit

3 Follow-up

Record represents a post-LSP/HC follow-up assessment

Type of Screening Visit
This variable indicates whether the record represents a baseline screening visit, a rescreening visit,
or a post-Lifestyle Program (LSP)/Health Coaching (HC) follow-up assessment.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants
9 No answer recorded

ANALYSIS AND USE

No answer recorded

To assess the number of unique women served by the WISEWOMAN Program
To track participants screening values over time
To link baseline screenings with rescreenings
To assess participants progress after completion of an LSP/HC

8

Item 3a: EncodeID

Unique Participant ID Number
This variable indicates a woman’s unique identification number.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Unique Participant ID

ANALYSIS AND USE

To assess the number of unique women served by the WISEWOMAN Program
To track participants over time
To link baseline screenings with rescreenings
To link screenings with risk reduction counseling, lifestyle programs, health coaching, and
community-based resource referrals

Value representing the unique identifier for a participant Number

9

Item 3b: ResANSI

ANSI Geographic Code of Residence
This variable indicates the ANSI geographic code of residence of the WISEWOMAN participant.

SOURCE

National ANSI Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

ANSI Geographic Code

ANALYSIS AND USE

To assess whether programs are meeting screening goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To assist in identifying areas where there may be potential transportation barriers to accessing
WISEWOMAN services

Value representing the participant’s geographic area of residence

10

Item 3c: ZIP

ZIP Code of Residence
This variable indicates the participant’s ZIP code of residence.

SOURCE

National ZIP Code List

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

ZIP Code of Residence

Valid five-digit (character) ZIP code

99999

No ZIP code recorded

ANALYSIS AND USE

To assess whether programs are meeting screening goals in targeted geographic areas
To identify the reach of the WISEWOMAN Program
To identify participant county of residence outside program state boundaries

11

Item 3d: MYB

Month and Year of Birth
This variable indicates the participant’s month and year of birth.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Month and Year of Birth

ANALYSIS AND USE

To estimate the age of the participant
To assist in characterizing the population reached by the WISEWOMAN Program

Month and Year of Birth in MM01CCYY format
Example: September 18, 1965 = 09011965

To provide data element required to determine participant’s cardiovascular risk or risk score
To assess whether the participants are within the Program’s priority age group

12

VALUES AND
DESCRIPTION

Item 3e: Latino

1 Yes

Participant reports that she is of Hispanic or Latino origin

2 No

Participant reports that she is not of Hispanic or Latino origin

7 Unknown

Participant is unsure whether she is of Hispanic or Latino origin

Hispanic or Latino Origin
This variable indicates whether the participant is of Hispanic or Latino origin.

SOURCE

United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants
9 No answer recorded

ANALYSIS AND USE

Participant has not reported whether she is of Hispanic or Latino origin

To assess the race/ethnicity of WISEWOMAN participants
To analyze screening, lifestyle programs, and other variables by ethnicity
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

13

Item 3f: Race1

Race: First Race
This variable indicates a race with which the participant identifies.

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 White

Participant identifies White as a race

2 Black or African
American

Participant identifies Black or African American as a race

3 Asian

Participant identifies Asian as a race

4 Native Hawaiian or
Other Pacific Islander

Participant identifies Native Hawaiian or Other Pacific Islander as a
race

5 American Indian or
Alaska Native

Participant identifies American Indian or Alaska Native as a race

7 Unknown

Participant does not know her race or does not identify with any of
the races listed above
If a participant is Hispanic and does not identify a race, this code
should be used

9 No answer recorded

Race information is missing for the participant
Any race information gathered should be entered beginning with the
Race1 field.

ANALYSIS AND USE

To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze screening, lifestyle programs, and other variables by race To
assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

Item 3g: Race2

Race: Second Race
This variable indicates a race with which the participant identifies in cases where a participant is
multiracial.

SOURCE

United States Census Bureau; United States Office of Management and Budget Guidelines

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN
participants

VALUES AND
DESCRIPTION

1 White

Participant identifies White as a race
Participant who has identified two or more races can have this value

2 Black or African
American

Participant identifies Black or African American as a race
Participant who has identified two or more races can have this value

3 Asian

Participant identifies Asian as a race
Participant who has identified two or more races can have this value

14

ANALYSIS AND USE

4 Native Hawaiian or
Other Pacific Islander

Participant identifies Native Hawaiian or Other Pacific Islander as a
race
Participant who has identified two or more races can have this value

5 American Indian or
Alaska Native

Participant identifies American Indian or Alaska Native as a race
Participant who has identified two or more races can have this value

7 Unknown

Participant does not know her race or does not identify with any of
the races listed above

9 No answer recorded

If race information is missing for Race2
Participant has not identified any race
Participant has identified one race and does not identify other races If
a participant does not identify a second race, ‘9 No answer recorded’
should be used for this field and all subsequent race fields

To assess the race/ethnicity of WISEWOMAN participants
To understand and analyze screening, lifestyle programs, and other variables by race
To assist in characterizing the population reached by the WISEWOMAN Program
To provide data element required to determine participant’s cardiovascular risk or risk score

Item 3h: Education

Education (highest grade completed)
This variable indicates the highest grade the participant completed.

SOURCE

CDC Behavioral Risk Factor Surveillance System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 <9th grade

Participant reports that she did not attend high school

2 Some high school

Participant reports she attended high school, but did not graduate

3 High school graduate
or equivalent

Participant reports that she graduated from high school or has the
equivalent of a high school diploma, and she did not attend any
college or higher education

4 Some college or higher

Participant reports that she attended one or more years of college
and/or graduate school (e.g., college graduate, graduate degree)

7 Don’t know/Not sure

Participant reports that she does not know the highest grade she
completed

8 Don’t want to answer

Participant does not want to answer the highest grade she completed

9 No answer recorded

Education information is missing for the participant

ANALYSIS AND USE

To assess the educational attainment of women in the WISEWOMAN population
To understand screening, lifestyle programs , and other variables by education status
To help determine the literacy level needed for materials developed for recruitment, risk
reduction counseling, lifestyle programs, health coaching, and community-based resources To
assist in characterizing the population reached by the WISEWOMAN Program

15

Item 3i: Language

What is the primary language spoken in your home?
This variable indicates the primary language spoken in the participant’s home.

SOURCE

National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 English

Participant identifies English as the primary language spoken in her
home

2 Spanish

Participant identifies Spanish as the primary language spoken in her
home

3 Arabic

Participant identifies Arabic as the primary language spoken in her
home

4 Chinese

Participant identifies Chinese as the primary language spoken in her
home

5 French

Participant identifies French as the primary language spoken in her
home

6 Italian

Participant identifies Italian as the primary language spoken in her
home

7 Japanese

Participant identifies Japanese as the primary language spoken in
her home

8 Korean

Participant identifies Korean as the primary language spoken in her
home

9 Polish

Participant identifies Polish as the primary language spoken in her
home

10 Russian

Participant identifies Russian as the primary language spoken in her
home

11 Tagalog

Participant identifies Tagalog as the primary language spoken in her
home

12 Vietnamese

Participant identifies Vietnamese as the primary language spoken in
her home

13 Creole

Participant identifies Creole as the primary language spoken in her
home

14 Portuguese

Participant identifies Portuguese as the primary language spoken in
her home

15 Hmong

Participant identifies Hmong as the primary language spoken in her
home

16

16 Other Language

Participant identifies another language as the primary language
spoken in her home (write-in response)

88 Don’t want to answer

Participant does not want to answer the primary language spoken in
her home

99 No answer recorded

Primary language information is missing for the participant

ANALYSIS AND USE

To assess the primary language of women in the WISEWOMAN population
To provide context to potential the health literacy issues
To assist in characterizing the population reached by the WISEWOMAN Program

Item 4a: SRHC

Do you have high cholesterol?
This variable indicates whether the participant has high cholesterol.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant has high cholesterol

2 No

Participant does not have high cholesterol

7 Don’t know/Not sure

Participant does not know whether she has high cholesterol The
validation program will flag this value for a quality check

8 Don’t want to answer

Participant does not want to answer whether she has high cholesterol
The validation tool will flag this value for a quality check

9 No answer recorded

No answer recorded
The validation tool will flag this value as an error

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of high cholesterol that have been previously diagnosed as
opposed to newly detected cases among the WISEWOMAN population
To assess control of and improvements in cholesterol for newly and previously diagnosed women

17

Item 4b: SRHB

Do you have hypertension (high blood pressure)?
This variable indicates whether the participant has hypertension (high blood pressure).

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant has hypertension (high blood pressure)

2 No

Participant does not have hypertension (high blood pressure)

7 Don’t know/Not sure

Participant does not know whether she has hypertension (high blood
pressure)
The validation program will flag this value for a quality check

8 Don’t want to answer

Participant does not want to answer whether she has hypertension
(high blood pressure)
The validation program will flag this value for a quality check

9 No answer recorded

No answer recorded
The validation tool will flag this value as an error

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension (high blood pressure) that have been previously
diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess control of and improvements in blood pressure for newly and previously diagnosed
women

Item 4c: SRD

Do you have diabetes? (either Type 1 or Type 2)
This variable indicates whether the participant has Type 1 or Type 2 diabetes.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant has Type 1 or Type 2 diabetes

2 No

Participant does not have Type 1 or Type 2 diabetes

7 Don’t know/Not sure

Participant does not know whether she has Type 1 or Type 2 diabetes

8 Don’t want to answer

Participant does not want to answer whether she has Type 1 or Type
2 diabetes

9 No answer recorded

No answer recorded

18

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of diabetes that have been previously diagnosed as opposed to
newly detected cases among the WISEWOMAN population
To assess control of and improvements in diabetes for newly and previously diagnosed women
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

19

Item 4d: SRHA

Have you been diagnosed by a healthcare provider as having any of these conditions:
coronary heart disease/chest pain, heart attack, heart failure, stroke/transient ischemic attack
(TIA), vascular disease, or congenital heart defects?
This variable indicates whether the participant has ever been diagnosed by a healthcare provider as
having coronary heart disease/chest pain, heart attack, heart failure, stroke/TIA, vascular disease,
or congenital heart defects.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant has been diagnosed by a healthcare provider as having
coronary heart disease/chest pain, heart attack, heart failure,
stroke/TIA, vascular disease, or congenital heart defects

2 No

Participant has never been diagnosed by a healthcare provider as
having coronary heart disease/chest pain, heart attack, heart failure,
stroke/TIA, vascular disease, or congenital heart defects

7 Don’t know/Not sure

Participant does not know whether she has been diagnosed by a
healthcare provider as having coronary heart disease/chest pain,
heart attack, heart failure, stroke/TIA, vascular disease, or congenital
heart defects

8 Don’t want to answer

Participant does not want to answer whether she has been diagnosed
by a healthcare provider as having coronary heart disease/chest pain,
heart attack, heart failure, stroke/TIA, vascular disease, or congenital
heart defects

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To understand the history of cardiovascular disease among individual participants and the overall
WISEWOMAN population
To assess the number of participants who have been previously diagnosed as having cardiovascular
disease
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

Item 5a: HCMeds

Do you take medication to lower your cholesterol?
This variable indicates whether the participant takes medication to lower her cholesterol.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with elevated cholesterol or previously
diagnosed with high cholesterol

VALUES AND
DESCRIPTION

1 Yes

Participant is taking medication to lower her cholesterol

2 No

Participant is not taking medication to lower her cholesterol

20

3 No – Could not obtain
medication

Participant is not taking medication to lower her cholesterol because
she could not obtain the medication (e.g., could not obtain due to cost
of medication, could not obtain due to expired prescription, could not
obtain due to problems getting the prescription filled because of lack
of transportation or access to a pharmacy)

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with high cholesterol

7 Don’t know/Not sure

Participant does not know whether she is taking medication to lower
her cholesterol

8 Don’t want to answer

Participant does not want to answer whether she is taking medication
to lower her cholesterol

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of high cholesterol that have been previously diagnosed as
opposed to newly detected cases among the WISEWOMAN population
To assess the control and management of cholesterol among participants who have high cholesterol
To assist in assessment of adherence to medication for high cholesterol

Item 5b: HBPMeds

Do you take medication to lower your blood pressure?
This variable indicates whether the participant is taking medication to lower her blood pressure.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with elevated blood pressure or previously
diagnosed with hypertension (high blood pressure)

VALUES AND
DESCRIPTION

1 Yes

Participant is taking medication to lower her blood pressure

2 No

Participant is not taking medication to lower her blood pressure

3 No – Could not obtain
medication

Participant is not taking medication to lower her blood pressure
because she could not obtain the medication (e.g., could not obtain
due to cost of medication, could not obtain due to expired
prescription, could not obtain due to problems getting the prescription
filled because of lack of transportation or access to a pharmacy)

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with high blood pressure

7 Don’t know/Not sure

Participant does not know whether she is taking medication to lower
her blood pressure

8 Don’t want to answer

Participant does not want to answer whether she is taking medication
to lower her blood pressure

9 No answer recorded

No answer recorded

21

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of hypertension (high blood pressure) that have been previously
diagnosed as opposed to newly detected cases among the WISEWOMAN population
To assess the control and management of hypertension (high blood pressure) among participants
who have hypertension (high blood pressure)
To assist in assessment of adherence to medication for hypertension (high blood pressure)

Item 5c: DMeds

Are you taking medication to lower your blood sugar (for diabetes)?
This variable indicates whether the participant is taking medication to lower her blood sugar for
diabetes.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with elevated blood glucose or A1C or
previously diagnosed with diabetes

VALUES AND
DESCRIPTION

1 Yes

Participant is taking medication to lower her blood sugar for diabetes

2 No

Participant is not taking medication to lower her blood sugar for
diabetes

3 No – Could not obtain
medication

Participant is not taking medication to lower her blood sugar for
diabetes because she could not obtain the medication (e.g., could not
obtain due to cost of medication, could not obtain due to expired
prescription, could not obtain due to problems getting the prescription
filled because of lack of transportation or access to a pharmacy)

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with high blood sugar for diabetes

7 Don’t know/Not sure

Participant does not know whether she is taking medication to lower
her blood sugar for diabetes

8 Don’t want to answer

Participant does not want to answer whether she is taking medication
to lower her blood sugar for diabetes

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To assess the number of cases of diabetes that have been previously diagnosed as opposed to
newly detected cases among the WISEWOMAN population
To assess diabetes control and management among participants who have diabetes
To assist in assessment of adherence to medication for diabetes

Item 5d: HCAdhere

During the past 7 days (including today), on how many days did you take prescribed
medication to lower your cholesterol?
This variable indicates the number of days out of the past 7 days, including the day of the
screening, that the participant took prescribed medication to lower her cholesterol.

22

SOURCE

Adapted from National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants taking medication to lower cholesterol

VALUES AND
DESCRIPTION

Number of days

A one-digit (numeric) value indicating the number of days out of the
past 7 days, including the day of the screening, that the participant
took prescribed medication to lower her cholesterol

0 None

In the past 7 days, including the day of the screening, the participant
did not take prescribed medication to lower her cholesterol

55 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with high cholesterol

77 Don’t know/Not sure

Participant is not sure whether she took prescribed medication to
lower her cholesterol during the past 7 days including the day of the
screening

88 Don’t want to answer

Participant did not want to answer whether she took prescribed
medication to lower her cholesterol during the past 7 days including
the day of the screening

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To facilitate assessment of adherence to medication prescribed for high cholesterol
To assist in determining high cholesterol management and control

Item 5e: HBPAdhere

During the past 7 days (including today), on how many days did you take prescribed
medication (including diuretics/water pills) to lower your blood pressure?
This variable indicates the number of days out of the past 7 days, including the day of the screening,
that the participant took prescribed medication (including diuretics/water pills) to lower her blood
pressure.

SOURCE

Adapted from National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants taking medication to lower blood pressure

VALUES AND
DESCRIPTION

Number of days

A one-digit (numeric) value indicating the number of days out of the
past 7 days, including the day of the screening, that the participant
took prescribed medication (including diuretics/water pills) to lower her
blood pressure

0 None

In the past 7 days, including the day of the screening, the participant
did not take prescribed medication (including diuretics/water pills) to
lower her blood pressure

55 Not Applicable

This question is not applicable for this patient because she has never
been diagnosed with hypertension (high blood pressure)

77 Don’t know/Not sure

Participant is not sure whether she took prescribed medication
(including diuretics/water pills) to lower her blood pressure during the
past 7 days including the day of the screening

23

88 Don’t want to answer

Participant did not want to answer whether she prescribed medication
(including diuretics/water pills) to lower her blood pressure during the
past 7 days including the day of the screening

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To facilitate assessment of adherence to medication prescribed for hypertension (high blood
pressure)
To assist in determining hypertension (high blood pressure) prevention, management, and control

Item 5f: DAdhere

During the past 7 days (including today), on how many days did you take prescribed
medication to lower blood sugar (for diabetes)?
This variable indicates the number of days out of the past 7 days, including the day of the screening,
that the participant took prescribed medication to lower her blood sugar (for diabetes).

SOURCE

Adapted from National Survey of Children’s Health

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants prescribed taking took prescribed medication
to lower blood sugar

VALUES AND
DESCRIPTION

Number of days

A one-digit (numeric) value indicating the number of days out of the
past 7 days, including the day of the screening, that the participant
took prescribed medication to lower her blood sugar (for diabetes)

0 None

In the past 7 days, including the day of the screening, the participant
did not take prescribed medication to lower her blood sugar (for
diabetes)

55 Not Applicable

This question is not applicable for this patient because she has never
been diagnosed with high blood sugar (for diabetes)

77 Don’t know/Not sure

Participant is not sure whether she took prescribed medication to
lower her blood sugar (for diabetes) during the past 7 days including
the day of the screening

88 Don’t want to answer

Participant did not want to answer whether she took prescribed
medication to lower her blood sugar (for diabetes) during the past 7
days including the day of the screening

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To facilitate assessment of adherence to medication prescribed for diabetes
To assist in determining diabetes control and management

Item 6a: BPHome

Do you measure your blood pressure at home or using other calibrated sources?
This variable indicates whether the participant monitors her blood pressure at home or using other
calibrated sources (select all response options that apply).

SOURCE

HealthStyles Survey

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with elevated blood pressure or those with
elevated blood pressure taking medication

24

VALUES AND
DESCRIPTION

1 Yes

Participant reports that she measures her blood pressure at home or
using other calibrated sources

2 No – Was never told to
measure her blood
pressure

Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she was never told
she should measure her blood pressure

3 No – Doesn’t know how
to measure her blood
pressure

Participant reports that she does not measure her blood pressure at
home or using other calibrated sources because she does not know
how to measure her blood pressure

4 No – Doesn’t have
Participant reports that she does not measure her blood pressure at
equipment to measure her home or using other calibrated sources because she does not have
blood pressure
access to the required equipment to measure her blood pressure
5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources

7 Don’t know/Not sure

Participant is not sure whether she measures her blood pressure at
home or using other calibrated sources

8 Don’t want to answer

Participant did not want to answer whether she measures her blood
pressure at home or using other calibrated sources

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)

Item 6b: BPFreq

How often do you measure your blood pressure at home or using other calibrated sources?
This variable indicates how frequently the participant measures her blood pressure at home or using
other calibrated sources.

SOURCE

HealthStyles Survey

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with elevated blood pressure or those with
elevated blood pressure taking medication who have indicated they measure their blood pressure at
home or using other calibrated sources

VALUES AND
DESCRIPTION

1 Multiple times per day

Participant measures her blood pressure at home or using other
calibrated sources multiple times per day

2 Daily

Participant measures her blood pressure at home or using other
calibrated sources once per day

3 A few times per week

Participant measures her blood pressure at home or using other
calibrated sources a few times per week

4 Weekly

Participant measures her blood pressure at home or using other
calibrated sources once per week

5 Monthly

Participant measures her blood pressure at home or using other
calibrated sources once per month

6 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources

25

7 Don’t know/Not sure

Participant is not sure how frequently she measures her blood
pressure at home or using other calibrated sources

8 Don’t want to answer

Participant did not want to answer how frequently she measures her
blood pressure at home or using other calibrated sources

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)

Item 6c: BPSend

Do you regularly share blood pressure readings with a health care provider for feedback?
This variable indicates whether the participant shares blood pressure readings taken at home or
using other calibrated sources with a health care provider for feedback almost every time she sees
her provider.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes WISEWOMAN participants with elevated blood pressure or those with
elevated blood pressure taking medication who have indicated they measure their blood pressure at
home or using other calibrated sources

VALUES AND
DESCRIPTION

1 Yes

Participant reports that she shares blood pressure readings taken at
home or using other calibrated sources with a health care provider for
feedback almost every time she sees her provider

2 No

Participant reports that she does not share blood pressure readings
taken at home or using other calibrated sources with a health care
provider for feedback

5 Not Applicable

This question is not applicable for the patient because she has never
been diagnosed with hypertension (high blood pressure) or does not
monitor her blood pressure at home or using other calibrated sources

7 Don’t know/Not sure

Participant is not sure whether she shares blood pressure readings
taken at home or using other calibrated sources with a health care
provider for feedback

8 Don’t want to answer

Participant did not want to answer whether she shares blood pressure
readings taken at home or using other calibrated sources with a
health care provider for feedback

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine self-control and management of hypertension (high blood pressure)
To determine whether blood pressure monitoring results are shared with a health care provided for
monitoring of progress

Item 7a: Fruit

How much fruit do you eat in an average day?
This variable indicates the amount of fruit the participant consumes in an average day.

SOURCE

American Heart Association Life’s Simple 7

26

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of cups

Two-digit (numeric) value representing the number of cups of fruit the
participant consumes in an average day

00 None

Participant does not consume fruit in an average day

88 Don’t want to answer

Participant does not want to answer how many cups of fruit she
consumes in an average day

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

27

Item 7b: Vegetables

How many vegetables do you eat in an average day?
This variable indicates the amount of vegetables the participant consumes in an average day.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
Number of cups Two-digit (numeric) value representing the number of cups of DESCRIPTION
vegetables the participant consumes in an average day

ANALYSIS AND USE

00 None

Participant does not consume vegetables in an average day

88 Don’t want to answer

Participant does not want to answer how many cups of vegetables
she consumes in an average day

99 No answer recorded

No answer recorded

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

28

Item 7c: Fish

Do you eat two servings or more of fish weekly?
This variable indicates whether the participant consumes two servings or more of fish weekly.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant consumes two servings or more of fish weekly

2 No

Participant does not consume two servings or more of fish weekly

8 Don’t want to answer

Participant does not want to answer whether she consumes two
servings or more of fish weekly

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

29

Item 7d: Grains

Do you eat 3 ounces or more of whole grains daily?
This variable indicates whether the participant consumes 3 ounces or more of whole grains daily.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant consumes 3 ounces or more of whole grains daily

2 No

Participant does not consume 3 ounces or more of whole grains daily

8 Don’t want to answer

Participant does not want to answer whether she consumes 3 ounces
or more of whole grains daily

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

30

Item 7e: Sugar

Do you drink less than 36 ounces (450 calories) of beverages with added sugars weekly?
This variable indicates whether the participant drinks less than 36 ounces (450calories) of
beverages with added sugars weekly.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant consumes less than 36 ounces (450 calories) of
beverages with added sugars in an average week

2 No

Participant consumes 36 ounces or more (450 calories or more) of
beverages with added sugars in an average week

8 Don’t want to answer

Participant does not want to answer whether she consumes less than
36 ounces (450 calories) or more of beverages with added sugars in
an average week

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

31

Item 7f: SaltWatch

Are you currently watching or reducing your sodium or salt intake?
This variable indicates whether the participant is currently watching or reducing her sodium or salt
intake.

SOURCE

CDC Behavioral Risk Factor Surveillance System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Yes

Participant is currently watching or reducing her sodium or salt intake

2 No

Participant is not currently watching or reducing her sodium or salt
intake

8 Don’t want to answer

Participant does not want to answer whether she is currently watching
or reducing her sodium or salt intake

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population

32

Item 8a: PAMod

How much moderate physical activity do you get in a week?
This variable indicates the amount of moderate physical activity the participant gets during an
average week.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of minutes

A three-digit (numeric) value representing the minutes of moderate
physical activity the participant gets during an average week

000 None

Participant does not get any moderate physical activity during an
average week

888 Don’t want to answer

Participant does not want to answer how much moderate physical
activity she gets during an average week

999 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

33

Item 8b: PAVig

How much vigorous physical activity do you get in a week?
This variable indicates the amount of vigorous physical activity the participant gets during an
average week.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of minutes

A three-digit (numeric) value representing the minutes of vigorous
physical activity the participant gets during an average week

000 None

Participant does not get any vigorous physical during an average
week

888 Don’t want to answer

Participant does not want to answer how much vigorous physical
activity she gets during an average week

999 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

34

Item 9a: Smoker

Do you smoke? Includes cigarettes, pipes, or cigars (smoked tobacco in any form) This
variable indicates whether the participant smokes tobacco in any form, including cigarettes,
pipes, or cigars.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Current Smoker

Participant currently smokes tobacco in any form, including
cigarettes, pipes, or cigars

2 Quit (1-12 months ago)

Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, 1 to 12 months ago

3 Quit (More than 12
months ago)

Participant quit smoking tobacco in any form, including cigarettes,
pipes, or cigars, more than 12 months ago

4 Never Smoked

Participant has never smoked tobacco in any form, including
cigarettes, pipes, or cigars

8 Don’t want to answer

Participant does not want to answer whether she smokes tobacco in
any form, including cigarettes, pipes, or cigars

9 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the healthy and risky behaviors of individual participants and the overall
WISEWOMAN population
To identify participants who might benefit from smoking cessation counseling and tobacco cessation
resources (quit line and community-based)
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

35

Item 9b: Sechand

About how many hours a day, on average, are you in the same room or vehicle with another
person who is smoking?
This variable indicates how many hours a day, on average, the participant is in the same room or
vehicle as another person who is smoking.

SOURCE

Pregnancy Risk Assessment Monitoring System

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of hours

A two-digit (numeric) value indicating the number of hours per day, on
average, the participant is in the same room or vehicle as another
person who is smoking

66 Less than one

Participant is in the same room or vehicle with another person who is
smoking less than one hour per day, on average

00 None

Participant is never in the same room or vehicle as another person
who is smoking

88 Don’t want to answer

Participant does not want to answer the number of hours per day, on
average, that she is in the same room or vehicle as another person
who is smoking

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the exposure of individual participants and the overall WISEWOMAN population to
risks in the environment
To help assess use of community-based referral resources and risk reduction counseling for those
exposed to secondhand smoke

36

Item 10a: QOLPH

Thinking about your physical health, which includes physical illness and injury, on how
many days during the past 30 days was your physical health not good?
This variable indicates the number of days during the past 30 days that the participant’s physical
health, including physical illness and injury, was not good.

SOURCE

CDC Health-Related Quality of Life Measures

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of days

A two-digit (numeric) value representing the number of days during
the past 30 days that the participant’s physical health, including
physical illness and injury, was not good

77 Don’t know/Not sure

Participant does not know how many days during the past 30 days
that her physical health, including physical illness and injury, was not
good

88 Don’t want to answer

Participant does not want to answer how many days during the past
30 days that her physical health, including physical illness and injury,
was not good

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the health status of individual participants and the overall WISEWOMAN population
To provide health status information for cost benefit or cost effectiveness analyses

37

Item 10b: QOLMH

Thinking about your mental health, which includes stress, depression, and problems with
emotions, on how many days during the past 30 days was your mental health not good?
This variable indicates the number of days during the past 30 days that the participant’s mental
health, including stress, depression, and problems with emotions, was not good.

SOURCE

CDC Health-Related Quality of Life Measures

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of days

A two-digit (numeric) value representing the number of days during
the past 30 days that the participant’s mental health, including stress,
depression, and problems with emotions, was not good

77 Don’t know/Not sure

Participant does not know how many days during the past 30 days
that the participant’s mental health, including stress, depression, and
problems with emotions, was not good

88 Don’t want to answer

Participant does not want to answer how many days during the past
30 days that the participant’s mental health, including stress,
depression, and problems with emotions, was not good

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the health status of individual participants and the overall WISEWOMAN population
To provide health status information for cost benefit or cost effectiveness analyses

38

Item 10c: QOLEffect

During the past 30 days, on about how many days did poor physical or mental health keep
you from doing your usual activities, such as self-care, work, or recreation?
This variable indicates the number of days during the past 30 days that the participant’s poor
physical or mental health kept her from doing her usual activities, such as self-care, work, or
recreation.

SOURCE

CDC Health-Related Quality of Life Measures

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of days

A two-digit (numeric) value representing the number of days during
the past 30 days that the participant’s poor physical or mental health
kept her from doing her usual activities, such as self-care, work, or
recreation

77 Don’t know/Not sure

Participant does not know how many days during the past 30 days
that the participant’s poor physical or mental health kept her from
doing her usual activities, such as self-care, work, or recreation

88 Don’t want to answer

Participant does not want to answer how many days during the past
30 days that the participant’s poor physical or mental health kept her
from doing her usual activities, such as self-care, work, or recreation

99 No answer recorded

No answer recorded

ANALYSIS AND USE

To determine the health status of individual participants and the overall WISEWOMAN population
To provide health status information for cost benefit or cost effectiveness analyses

39

Item 11a: Height

Height
This variable indicates the participant’s height in inches.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Height in inches

Up to a two-digit (numeric) value representing the participant’s height

777 Unable to obtain

Height measurement was attempted, but measurement results were
not obtained

888 Client refused

Participant refuses to have her height measurement taken

999 No measurement
recorded

Height measurement was not performed

ANALYSIS AND USE

To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

40

Item 11b: Weight

Weight
This variable indicates the participant’s weight in pounds.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Weight in pounds

Up to a three-digit (numeric) value representing the participant’s
weight

777 Unable to obtain

Weight measurement was attempted, but measurement results were
not obtained

888 Client refused

Participant refuses to have her weight measurement taken

999 No measurement
recorded

Weight measurement was not performed

ANALYSIS AND USE

To calculate the BMI of WISEWOMAN participants
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

41

Item 11c: Waist

Waist Circumference
This variable indicates the participant’s waist circumference in inches.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Waist Circumference in inches

Up to a two-digit (numeric) value representing the participant’s
waist circumference in inches

777 Unable to obtain

Waist circumference measurement was attempted, but
measurement results were not obtained

888 Client refused

Participant refuses
measurement taken

999 No measurement recorded

Waist circumference measurement was not performed

ANALYSIS AND USE

to

have

her

waist

circumference

To determine waist-hip ratio for the participant
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population

42

Item 11d: Hip

Hip Circumference
This variable indicates the participant’s hip circumference in inches.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Hip Circumference in inches

Up to a two-digit (numeric) value representing the participant’s hip
circumference in inches

777 Unable to obtain

Hip circumference measurement was attempted, but
measurement results were not obtained

888 Client refused

Participant refuses to have her hip circumference measurement
taken

999 No measurement

ANALYSIS AND USE

Hip circumference measurement was not performed recorded

To determine waist-hip ratio for the participant
To understand the cardiovascular disease risk factors of individual participants and the overall
WISEWOMAN population

43

Item 12a: BPDate

Blood Pressure Measurement Date (Office Visit Date)
This variable indicates the date of the office visit when a blood pressure measurement is obtained.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Blood pressure
measurement date/Office
measurement is visit date

ANALYSIS AND USE

Valid date in MMDDCCYY format
Date of the office visit and when a blood pressure
obtained

To identify the date of the office visit and blood pressure measurements
To facilitate analysis of changes in blood pressure over time
To calculate other service time frames, including time to rescreening, lifestyle program sessions,
lifestyle program/health coaching follow-up screening, risk reduction counseling sessions, alert
referrals, and labs

44

Item 12b: SBP1

Systolic Blood Pressure #1
This variable indicates the participant’s first systolic blood pressure reading.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Systolic blood pressure in Up to a three-digit (numeric) value representing the participant’s first
mmHg
systolic blood pressure in mmHg

ANALYSIS AND USE

777 Unable to obtain

First systolic blood pressure measurement was attempted, but results
were not obtained due to technical difficulties or errors

888 Client refused

Participant refuses to have her first systolic blood pressure
measurement taken

999 No measurement
recorded

First systolic blood pressure measurement was not performed or not
recorded

To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension (high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

45

Item 12c: DBP1

Diastolic Blood Pressure #1
This variable indicates the participant’s first diastolic blood pressure reading.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Diastolic blood pressure
in mmHg

Up to a three-digit (numeric) value representing the participant’s
diastolic blood pressure in mmHg

777 Unable to obtain

First diastolic blood pressure measurement was attempted, but results
were not obtained due to technical difficulties or errors

888 Client refused

Participant refuses to have her first diastolic blood pressure
measurement taken

999 No measurement
recorded

First diastolic blood pressure measurement was not performed or not
recorded

ANALYSIS AND USE

To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension(high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

46

Item 12d: SBP2

Systolic Blood Pressure #2
This variable indicates the participant’s second systolic blood pressure reading.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Systolic blood pressure in Up to a three-digit (numeric) value representing the participant’s
mmHg
second systolic blood pressure in mmHg
777 Unable to obtain
888 Client refused
999 No measurement
recorded

ANALYSIS AND USE

Second systolic blood pressure measurement was attempted, but
results were not obtained due to technical difficulties or errors
Participant refuses to have her second systolic blood pressure
measurement taken
Second systolic blood pressure measurement was not performed or
not recorded

To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension (high blood pressure) for referral to
medical management
To determine control and management of blood pressure among those currently being treated
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk in the WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

47

Item 12e: DBP2

Diastolic Blood Pressure #2
This variable indicates the participant’s second diastolic blood pressure reading.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Diastolic blood pressure
in mmHg

Up to a three-digit (numeric) value representing the participant’s
diastolic blood pressure in mmHg

777 Unable to obtain

Second diastolic blood pressure measurement was attempted, but
results were not obtained due to technical difficulties or errors

888 Client refused

Participant refuses to have her second diastolic blood pressure
measurement taken

999 No measurement
recorded

Second diastolic blood pressure measurement was not performed or
not recorded

ANALYSIS AND USE

To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure,
stroke, and kidney disease
To identify participants who would benefit from lifestyle programs
To identify participants unaware that they have hypertension (high blood pressure) for referral to
medical management
To determine control and management of blood pressure
To identify participants who require further diagnostic evaluation
To identify hypertension (high blood pressure) risk of the WISEWOMAN population
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

48

Item 13a: Fast

Fasting Status
This variable indicates whether a participant fasted for at least nine hours prior to having blood
drawn for cholesterol or glucose measurements.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND 1 Yes Participant fasted for at least nine hours prior to having blood drawn DESCRIPTION
2 No

Participant did not fast for at least nine hours prior to having blood
drawn

9 No answer recorded

No answer recorded
Provider failed to confirm fasting status or no information is available
from the provider

ANALYSIS AND USE

To facilitate accurate identification of participants who have high cholesterol, borderline high
cholesterol, diabetes, or pre-diabetes

49

Item 14a: TCDate

Cholesterol Measurement Date
This variable indicates the date that the cholesterol measurements were taken.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Screening Date

ANALYSIS AND USE

To determine the date of the cholesterol measurements
To facilitate analysis of changes in control and management of cholesterol over time

Valid date in MMDDCCYY format
The date recorded in this field must be the date that the total and
HDL cholesterol values were taken; total cholesterol and HDL
measurements are minimum requirements for every participant If
a lipid panel is completed as part of the screening process, the
date recorded must be the date that the lipid panel was done

50

Item 14b: TotChol

Total Cholesterol (fasting or nonfasting)
This variable indicates the participant’s total cholesterol level.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Total cholesterol in
mg/dL

Up to a three-digit (numeric) value representing the participant’s total
cholesterol in mg/dL

777 Inadequate blood
sample

Total cholesterol measurement was attempted, but results were not
obtained due to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork

888 Client refused

Participant refuses to have her blood drawn for cholesterol
measurements
If the participant refuses to go to the lab, the participant can be
considered to have refused
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused

999 No measurement
recorded

No total cholesterol measurement was taken or recorded

ANALYSIS AND USE

To identify participants who are unaware that they have high or borderline high cholesterol and
need preventive services or referral to medical management
To determine cholesterol control and management
To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline
high cholesterol
To assess the risk in the WISEWOMAN population for cardiovascular disease
To provide data element required to determine participant’s Simple 7 cardiovascular risk score

Item 14c: HDL

HDL Cholesterol (fasting or nonfasting)
This variable indicates the participant’s HDL cholesterol level.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN
participants

VALUES AND
DESCRIPTION

HDL cholesterol in mg/dL

Up to a three-digit (numeric) value representing the participant’s HDL
cholesterol in mg/dL

777 Inadequate blood
sample

HDL cholesterol measurement was attempted, but results were not
obtained due to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork

51

888 Client refused

Participant refuses to have her blood drawn for cholesterol
measurements
If the participant refuses to go to the lab, the participant can be
considered to have refused
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused

999 No measurement
recorded

No HDL cholesterol measurement was taken or recorded

ANALYSIS AND USE

To identify participants who are unaware that they have low HDL cholesterol and need preventive
services or referral to medical management
To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline
high cholesterol
To assess the risk of the WISEWOMAN population for cardiovascular disease
To assist in determining cholesterol control and management

Item 14d: LDL

LDL Cholesterol (fasting)
This variable indicates a fasting participant’s fasting LDL cholesterol level.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

LDL cholesterol in mg/dL

Up to a three-digit (numeric) value representing a fasting participant’s
fasting LDL cholesterol in mg/dL

777 Inadequate blood
sample

LDL cholesterol measurement was attempted, but results were not
obtained due to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3)
sample submitted to laboratory, test not done due to erroneous or
missing laboratory request or other paperwork
This response should be used for participants who were confirmed to
be fasting, but their LDL cholesterol was unable to be obtained

888 Client refused

Participant refuses to receive a lipid panel that would include LDL
measurements
This response should be used for participants who were confirmed to
be fasting, but refused a lipid panel

999 No measurement
recorded

No LDL cholesterol measurement was taken or recorded
Nonfasting participants should always have this value

ANALYSIS AND USE

To assist in determining cholesterol control and management

52

Item 14e: Trigly

Triglycerides (fasting)
This variable indicates a fasting participant’s triglycerides measurement.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN
participants

VALUES AND
DESCRIPTION

Triglycerides in mg/dL

Up to a four-digit (numeric) value representing a fasting participant’s
triglycerides measurement in mg/dL

7777 Inadequate blood
sample

Triglycerides measurement was attempted, but results were not
obtained due to technical difficulties or errors
This may include issues such as (1) two or more failed venipuncture
attempts; (2) insufficient amount of blood, type of test tube; (3) sample
submitted to laboratory, test not done due to erroneous or missing
laboratory request or other paperwork
This response should be used for participants who were confirmed to be
fasting, but their triglycerides measurement could not be obtained

8888 Client refused

Fasting participant refuses to receive a lipid panel that would include
triglycerides measurements
This response should be used for participants who were confirmed to be
fasting, but refused a lipid panel

9999 No measurement
recorded

No triglycerides measurement was taken or recorded
Nonfasting participants should always have this value

ANALYSIS AND USE

To assist in determining cholesterol control and management

53

Item 15a: BGDate

Glucose/A1c Measurement Date
This variable indicates the date that the glucose or A1C measurements were taken.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Screening Date

ANALYSIS AND USE

To determine the date of the glucose or A1C measurements
To facilitate analysis of changes in glucose or A1C measurements over time

Valid date in MMDDCCYY format

54

Item 15b: Glucose

Glucose (fasting)
This variable indicates the participant’s fasting glucose measurement.

SOURCE

American Heart Association Life’s Simple 7

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN
participants

VALUES AND
DESCRIPTION

Total glucose in mg/dL

Up to a three-digit (numeric) value representing the participant’s
fasting glucose level in mg/dL

777 Inadequate blood
sample

Glucose measurement was attempted, but results were not obtained
due to technical difficulties or errors

888 Client refused

Participant refuses to have her blood drawn for glucose
measurements
If the participant refuses to go to the lab, the participant can be
considered to have refused
If the participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused

999 No measurement
recorded

No glucose measurement was taken or record

ANALYSIS AND USE

To identify participants who have pre-diabetes and diabetes
To assist in determining diabetes control and management
To use in conjunction with A1C percentage (14c: A1C) to accurately assess a participant’s blood
glucose
To provide data element required to determine participant’s Simple 7 cardiovascular risk score
To understand the overall rate of diabetes among the WISEWOMAN population

Item 15c: A1C

A1C Percentage
This variable indicates the participant’s A1C percentage (if measured).

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN
participants

VALUES AND
DESCRIPTION

A1C percentage

Numeric value representing the participant’s A1C percentage. A1C
should be reported to one decimal point
If A1C was measured by another provider within the last 3 months, it
is acceptable to input the value if it is available

7777 Inadequate blood
sample

A1C measurement was attempted, but results were not obtained due
to technical difficulties or errors

55

8888 Client refused

Participant refuses to have an A1C test
If a participant refuses to go to the lab, the participant can be
considered to have refused
If a participant does not go to the scheduled lab appointment after
follow-up has been attempted, the participant can be considered to
have refused

9999 No measurement
recorded

No A1C measurement was taken or recorded

ANALYSIS AND USE

To identify participants who have diabetes and refer them for medical management
To identify participants who have higher-than-optimal A1C levels and would benefit from preventive
services such as lifestyle programs
To assist in determining diabetes control and management
To assess the cardiovascular disease risk factors in the WISEWOMAN population

Item 16a: BPAlert

If average SBP >180 or DBP >110, what is the status of the workup?
This variable indicates the status of the workup of a participant’s alert level blood pressure.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Workup complete

Workup for participant with an alert level blood pressure reading is
complete

2 Follow-up – workup by
alternate provider

Patient intends to see an alternate provider within 7 days

3 Not an alert reading

Participant did not have an alert level blood pressure reading

8 Client refused workup

Participant had an alert level blood pressure reading but refused
workup

9 Workup not completed,
client lost to follow-up

Participant had an alert level blood pressure reading but was lost to
follow-up, and workup was not completed
Lost to follow-up is defined as a participant who did not attend her
scheduled workup within three months after a screening visit and
could not be reached to reschedule another appointment

ANALYSIS AND USE

To assess whether participants with alert level blood pressure readings are receiving a workup
To assist in determining hypertension (high blood pressure) management, and control

56

Item 16b: BPDiDate

If Average SBP >180 or DBP >110, Workup Date
This variable indicates the workup date for a participant with an alert level blood pressure reading.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

Participants who have an alert level blood pressure value are included in the denominator

VALUES AND
DESCRIPTION

Blood Pressure Workup

ANALYSIS AND USE

Date

Valid date in MMDDCCYY format
If follow-up information is provided for this referral, the workup date
can be entered

To assess whether providers are performing timely workups for participants with alert level blood
pressure values
To determine whether programs are meeting the guideline of workups within one week of the
screening for alert participants
To assist in determining hypertension (high blood pressure) prevention, management, and control

57

Item 16c: BGAlert

If GLUCOSE ≤50 or GLUCOSE ≥250, what is the status of the workup?
This variable indicates the status of the workup of a participant’s alert level blood glucose.

SOURCE

Not applicable; health screening measurement

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN
participants

VALUES AND
DESCRIPTION

1 Workup complete

Workup for participant with an alert level fasting glucose reading is
complete

2 Follow-up – work up by
alternate provider

Patient intends to see an alternate provider within 7 days

3 Not an alert reading

Participant does not have an alert level fasting glucose reading

8 Client refused workup

Participant had an alert level fasting glucose reading but refused
workup

9 Workup not completed,
client lost to follow-up

Participant had an alert level fasting glucose reading but was lost to
follow-up, and workup was not completed
Lost to follow-up is defined as a participant who did not attend her
scheduled workup within three months after a screening visit and was
unable to be reached to reschedule another appointment

ANALYSIS AND USE

To assess whether participants with alert level blood glucose readings are receiving workup
To assist in determining diabetes prevention, management, and control

58

Item 16d: BGDiDate

If GLUCOSE ≤50 or GLUCOSE ≥250 Workup Exam Date
This variable indicates the workup date for a participant with an alert level fasting blood glucose
reading.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

Participants who have alert level fasting glucose values are included in the denominator.

VALUES AND
DESCRIPTION

Blood glucose workup

ANALYSIS AND USE

date

Valid date in MMDDCCYY format
If follow-up information is provided for this referral, the workup date
can be entered

To assess whether providers are performing timely workups for participants with alert level fasting
blood glucose values
To determine whether programs are meeting the guideline of workup within one week of the
screening for alert participants

59

Item 17a: RRCDate

Risk Reduction Counseling Date
This variable indicates the date that the initial risk reduction counseling occurred.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

counseling date
Risk reduction Valid date in MMDDCCYY format
Date must occur within the submission period

ANALYSIS AND USE

To determine the date of the risk reduction counseling
To assess receipt of risk reduction counseling to inform analyses of behavior change
To facilitate analysis of changes in risk reduction counseling provision over time

60

Item 17b: RRCComplete

Risk Reduction Counseling Completion Date
This variable indicates the date that risk reduction counseling was completed.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Risk reduction
counseling follow-up

ANALYSIS AND USE

To determine the date of a completed risk reduction counseling session
To facilitate analysis of changes in risk reduction counseling provision over time

Valid date in MMDDCCYY format
Date must occur within the submission period date

61

Item 17c: RRCNut

Participant Decided Nutrition Is A Priority Area
This variable indicates whether the participant decided that nutrition is a priority area after receiving
risk reduction counseling.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants that received risk reduction counseling

VALUES AND
DESCRIPTION

1 Yes

Participant decided that nutrition is a priority area

2 No

Participant did not decide that nutrition is a priority area

7 Unknown

It is unknown whether the participant decided that nutrition is a priority
area

ANALYSIS AND USE

To determine the number of participants that decided nutrition is a priority area after receiving risk
reduction counseling
To assist in determining participant health education on cardiovascular disease risk factors
To assist in assessments of reduction of risk over time in context of types of counseling received

62

Item 17d: RRCPA

Participant Decided Physical Activity Is A Priority Area
This variable indicates whether the participant decided that physical activity is a priority area after
receiving risk reduction counseling.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants that received risk reduction counseling

VALUES AND
DESCRIPTION

1 Yes

Participant decided that physical activity is a priority area

2 No

Participant did not decide that physical activity is a priority area

7 Unknown

It is unknown whether the participant decided that physical activity is
a priority area

ANALYSIS AND USE

To determine the number of participants that decided physical activity is a priority area after receiving
risk reduction counseling
To assist in determining participant health education on cardiovascular disease risk factors
To assist in assessments of reduction of risk over time in context of types of counseling received

63

Item 17e: RRCSmoke

Participant Decided Smoking Cessation Is A Priority Area
This variable indicates whether the participant decided that smoking cessation is a priority area after
receiving risk reduction counseling.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants that have received risk reduction
counseling and are smokers and those exposed to second hand smoke

VALUES AND
DESCRIPTION

1 Yes

Participant decided that smoking cessation is a priority area

2 No

Participant did not decide that smoking cessation is a priority area

7 Unknown

It is unknown whether the participant decided that smoking cessation
is a priority area

ANALYSIS AND USE

To determine the number of participants that decided smoking cessation is a priority area after
receiving risk reduction counseling
To assist in determining participant health education on cardiovascular disease risk factors
To assist in assessments of reduction of risk over time in context of types of counseling received

64

Item 17f:
RRCMedAdhere

Participant Decided Medication Adherence for Hypertension (high blood pressure) Is A Priority
Area
This variable indicates whether the participant decided medication adherence for her hypertension
(high blood pressure) is a priority area after receiving risk reduction.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants taking medication for hypertension (high
blood pressure) and received risk reduction counseling

VALUES AND
DESCRIPTION

1 Yes

Participant decided that medication adherence for hypertension (high
blood pressure) is a priority area

2 No

Participant did not decide that medication adherence for hypertension
(high blood pressure) is a priority area

7 Unknown

It is unknown whether the participant decided that medication
adherence for hypertension (high blood pressure) is a priority area

ANALYSIS AND USE

To determine the number of participants that decided that medication adherence for hypertension
(high blood pressure) is a priority area after receiving risk reduction counseling
To assist in determining hypertension (high blood pressure) prevention, management, and control
To assist in determining participant health education on cardiovascular disease risk factors
To assist in assessments of reduction of risk over time in context of types of counseling received

65

Item 18a: RTCDate

Readiness to Change Assessment Date
This variable indicates the date that an assessment of readiness to change occurred.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Readiness to change
assessment date

ANALYSIS AND USE

To determine the date of the readiness to change assessment
To assist in determining whether the participant has received an assessment of readiness to
change
To facilitate analysis of changes in readiness to change for the participant and for the program over
time

Valid date in MMDDCCYY format

66

Item 18b: RTC

Participant Stage of Change
This variable indicates the participant’s state of change based on a readiness to change
assessment.

SOURCE

Prochaska, JO.; DiClemente, CC. The transtheroretical approach. In: Norcross, JC; Goldfried, MR.
(eds.) Handbook of psychotherapy integration. 2nd ed. New York: Oxford University Press; 2005. p.
147–171.

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Pre-contemplation

Participant has little or no intention to change her behavior in the
foreseeable future

2 Contemplation

Participant is thinking about making a change in her behavior

3 Preparation

Participant is ready to plan how she will make a change in her
behavior

4 Action

Participant is in the process of trying to make a change in her
behavior

5 Maintenance

Participant is trying to maintain a change she has made in her
behavior

8 Refused

Participant refused to answer readiness to change assessment
questions

9 No answer recorded

No answer was recorded

ANALYSIS AND USE

To assess participant’s stage of change based on a readiness to change assessment
To facilitate analysis of changes in readiness to change for the participant and for the program over
time
To assist in assessments of participant behavior change outcomes in context of readiness to change

Item 19a: RefDate

Lifestyle Program (LSP) / Health Coaching (HC) Referral Date
This variable indicates the date that a referral to a LSP/HC occurred.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

The denominator includes all WISEWOMAN participants

VALUES AND
DESCRIPTION

Lifestyle Program/Health Valid date in MMDDCCYY format Coaching
Referral Date

ANALYSIS AND USE

To determine the date of the referral to a LSP/HC
To assist in determining whether the participant has received a referral to a LSP/HC
To assist in determining the number of LSP/HC referrals per participant
To facilitate analysis of changes in LSP/HC referrals over time

67

Item 20a: LSPHCRec

Number of Lifestyle Program (LSP) / Health Coaching (HC) Sessions Received by the
Participant
This variable indicates the number of LSP/HC sessions the participant has received.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants

VALUES AND
DESCRIPTION

Number of Sessions

ANALYSIS AND USE

To track the number of LSP/HC sessions that the participant has received
To assess LSP/HC sessions in context of types and settings, and readiness to change of a
participant

Value representing the number of LSP/HC sessions the participant has
received (includes current LSP/HC session)

68

Item 20b: Intervention

Date of Lifestyle Program (LSP) / Health Coaching (HC) Session
For LSP/HC records, this variable indicates the date that the LSP/HC session occurred.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants

VALUES AND
DESCRIPTION

Lifestyle Program/Health Valid date in MMDDCCYY format Coaching
Session Date

ANALYSIS AND USE

To determine the date of the LSP/HC session
To assist in determining whether the participant has received an LSP/HC session
To assist in calculating the number of LSP/HC sessions per participant
To assess whether participants with risk factors receive LSP/HC services
To assess changes in risk profile between participants who participate in the LSP/HC and
participants who do not

69

Item 20c: LSPHCID

Lifestyle Program (LSP) / Health Coaching (HC) ID This
variable indicates which LSP/HC was used.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants

VALUES AND
DESCRIPTION

Lifestyle Program ID

Value representing the ID code of the LSP as assigned

Health Coaching ID

Value representing the ID code of the HC as assigned

ANALYSIS AND USE

To track the number of WISEWOMAN participants who receive an LSP/HC session from each
WISEWOMAN LSP/HC provider
To describe differences in participant demographics or other characteristics by LSP/HC provider To
identify the number of LSP/HC providers in a given geographic area

70

Item 20d: LSPHCTime

Length of Lifestyle Program (LSP) / Health Coaching (HC) Session Received by the
Participant
This variable indicates the length (in minutes) of the LSP/HC session the participant has received.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC sessions among WISEWOMAN participants

VALUES AND
DESCRIPTION

Length of Session

ANALYSIS AND USE

To track the length of the LSP/HC sessions that the participant has received
To assess LSP/HC sessions in context of types and settings, and readiness to change of a
participant

Value representing the length of the LSP/HC session in minutes

71

Item 20e: ContactType

Type of Lifestyle Program (LSP) / Health Coaching (HC) Session This
variable indicates the type LSP/HC session.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC contacts among WISEWOMAN participants

VALUES AND
DESCRIPTION

1 Face-to-face

LSP/HC session was completed face-to-face

2 Phone

LSP/HC session was completed by phone

3Smart phone/tablet
Application

LSP/HC session was completed with a smart phone or tablet
application session. The program has received evidence that the
application session was completed.

4 Evidence that mailed
LSP/HC session was completed by review of mailed materials. The
materials were opened and program has received evidence that the materials were opened and
reviewed
reviewed
5 Evidence that audiotape
or DVD as opened and
reviewed

LSP/HC session was completed by review of an audiotape or DVD.
The program has received evidence that the audiotape or DVD was
opened and reviewed

6 Evidence that
noninteractive
computerbased session
was completed

LSP/HC session was completed with a computer-based session that
did not involve an interactive component. The program has received
evidence that the computer-based session was completed

7 Evidence that interactive LSP/HC session was completed with a computer-based session that
computerbased session
involved an interactive component. The program has received
was completed
evidence that the interactive computer-based session was
completed.

ANALYSIS AND USE

0 Other

Other LSP/HC session type.

99 No answer recorded

No answer was recorded

To assess how frequently different types of LSP/HC sessions are being used within and across
programs
To determine whether frequency of LSP/HC session types are consistent with programs’ LSP
models
To assess LSP/HC sessions in context of types and settings, and readiness to change of a
participant

Item 20f: Setting

Setting of Lifestyle Program (LSP) / Health Coaching (HC) Session
This variable indicates the setting of the LSP/HC session.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All LSP/HC contacts among WISEWOMAN participants

VALUES AND

1 Individual

LSP/HC contact for the participant occurred as an individual session

72

DESCRIPTION

ANALYSIS AND USE

2 Group

LSP/HC contact for the participant occurred as a group session

3 Combination

LSP/HC contact for the participant occurred as a combination of
individual and group sessions

9 No answer recorded

No answer was recorded

To assess how frequently different types of LSP/HC settings are being used within and across
programs
To determine whether the settings of LSP/HC sessions are consistent with programs’ LSP/HC
models
To assess LSP/HC sessions in context of types and settings, and readiness to change of a
participant

73

Item 20g:
LSPHCComp

Completion of Lifestyle Program (LSP) / Health Coaching (HC)

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All WISEWOMAN participants participating in an LSP/HC program

VALUES AND
DESCRIPTION

1 Yes – Lifestyle Program/Health
Coaching is Complete

Participant has completed the LSP/HC. An LSP requires
multiple sessions, e.g., multiple sessions in a curriculum

2 Yes – Intensive Follow-Up

Participant is in intensive follow-up following LSP/HC
completion

3 No – Lifestyle Program/Health
Coaching is still in progress

Participant’s LSP/HC is still in progress

4 No – Withdrawal/Discontinued

Participant has withdrawn from the LSP/HC or discontinued
the LSP/HC

9 No answer recorded

No answer was recorded for completion of LSP/HC

ANALYSIS AND USE

This variable indicates if the participant has completed the LSP/HC.

To determine whether the participant has completed an LSP/HC
To assist in determining the date of the participant’s final LSP/HC session in the program
To assess changes in risk profile between participants who complete the LSP/HC and participants
who do not

74

Item 21a: TobResDate

Date of Referral to Tobacco Cessation Resource
This variable indicates the date that the referral to a tobacco cessation resource occurred.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All tobacco cessation resource referrals among WISEWOMAN participants

VALUES AND
DESCRIPTION

Tobacco Cessation
Referral Date

ANALYSIS AND USE

To document the date of a referral to tobacco cessation resource
To assist in tracking receipt of tobacco cessation resource

Valid date in MMDDCCYY format Resource

75

Item 21b: TobResType

Type of Tobacco Cessation Resource Activity
This variable indicates the type of tobacco cessation resource activity that the participant was
referred to.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All contacts among WISEWOMAN participants who identify themselves as current smokers

VALUES AND
DESCRIPTION

1 Quit Line

Participant was referred to a Proactive Tobacco Quit Line

2 Community-based tobacco
program

Participant was referred to a community-based tobacco
program

3 Other tobacco cessation
resources

Participant was referred to other tobacco cessation
resources

9 No answer recorded

No answer was recorded

ANALYSIS AND USE

To determine the number of smokers that received a referral to tobacco cessation resource To
determine how frequently different types of tobacco cessation resources are being used within
and across programs
To compare the smoking status at rescreening and follow-up of women who were linked to tobacco
cessation resources versus those who were not

76

Item21c:TobResComp

Tobacco Cessation Resource Activity Completed
This variable indicates whether the participant completed tobacco cessation resource activity.

SOURCE

Not applicable; WISEWOMAN-specific variable

DENOMINATOR
POPULATION

All contacts among WISEWOMAN participants who identify themselves as current smokers

VALUES AND
DESCRIPTION

1 Yes – Completed tobacco
cessation resource activity

Participant completed tobacco cessation resource activity

2 No – Partially completed
Participant partially completed tobacco cessation resource
tobacco cessation resource activity activity
3 No – Withdraw from tobacco
cessation resource activity when
reached

Participant withdrew/refused tobacco cessation resource
activity when contacted

4 No – Could not reach to conduct Participant could not be reached when contacted by the
tobacco cessation resource activity tobacco cessation resource activity
9 No answer recorded

ANALYSIS AND USE

No answer was recorded

To determine the number of smokers that participated in tobacco cessation resource activities
To compare the smoking status at rescreening and follow-up of women who were linked to tobacco
cessation resources versus those who were not

77